Trump’s FDA wants a new trial for Novavax’s COVID-19 shot, sparking uncertainty about updates to other vaccines

Quick Summary:

The unusual move at FDA come shortly after the agency's longtime vaccine chief was forced out over disagreements with Health Secretary Robert F.Kennedy Jr.

Since that highly unusual move, Novavax and the agency have been discussing additional requirements for approval.

The nation's other two options, mRNA vaccines made by Pfizer and Moderna, have earned full FDA approval for certain age groups.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Lauran Neergaard, Matthew Perrone, The Associated Press

Category: EconomyBusiness

Markets: United States

Topics: Anti-vaccination COVID-19 vaccines FDA RFK Jr. Vaccines

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-04-29 @ 12:14:28 (13 hours ago)

News Timezone: GMT +8:00

News Source URL: fortune.com

Language: English

Article Length: 735 words

Reading Time: 5 minutes read

Sentences: 5 lines

Sentence Length: 147 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Fortune

News ID: 28285710

View Article Analysis

About Fortune

Main Topics: EconomyBusiness

Official Website: fortune.com

Update Frequency: 52 posts per day

Year Established: 1929

Headquarters: United States

News Last Updated: 8 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #95

Publisher Details

Frequently Asked Questions